Skip Navigation

European Heart Journal 2004 25(24):2226-2231; doi:10.1016/j.ehj.2004.07.020
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zrenner, B.
Right arrow Articles by Schmitt, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zrenner, B.
Right arrow Articles by Schmitt, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical research

Transvenous cryoablation versus radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal re-entrant tachycardia: a prospective randomized pilot study

Bernhard Zrenner*,1, Jun Dong*,1, Jürgen Schreieck, Isabel Deisenhofer, Heidi Estner, Blerim Luani, Martin Karch and Claus Schmitt

Deutsches Herzzentrum München und 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Lazarettstrasse 36, 80636 Munich, Germany

Received 19 March 2004; revised 25 June 2004; accepted 15 July 2004 * Corresponding authors. Tel.: +49 89 121 82020; fax: +49 89 121 84593 (E-mail: Zrenner{at}dhm.mhn.de).

AIMS: This is a prospective, randomized study comparing transvenous cryoablation with radiofrequency (RF) ablation of atrioventricular nodal re-entrant tachycardia (AVNRT).

METHODS AND RESULTS: In this pilot trial, 200 patients with AVNRT were randomized to undergo cryoablation or RF ablation of the slow pathway. A 7 Fr 4-mm-tip cryocatheter (Cryocath®) was used for cryomapping and cryoablation. Cryomapping was performed at the temperature of –30 °C to test the effect on the candidate ablation site. Following successful cryomapping, cryoablation was performed to produce an irreversible lesion by freezing to –75 °C. Procedural success, defined as elimination of the slow pathway or noninducibility of AVNRT, was achieved in 97/100 (97%) patients in the Cryo group vs. 98/100 (98%) patients in the RF group. No permanent complete AV-block occurred in either group. During a median of 246 days of follow-up, 8 patients in the Cryo group and 1 in the RF group had AVNRT recurrence. The cumulative incidence of primary endpoint (a combination of procedural failure, permanent complete AV-block and AVNRT recurrence) was significantly higher in the Cryo group than in the RF group (P=0.03, Log-rank test).

CONCLUSIONS: The results of this pilot study indicate that transvenous cryoablation using a 4-mm-tip cryocatheter is associated with a comparable acute success rate but a higher recurrence rate as compared with RF ablation in patients with AVNRT. Potential benefits of cryoablation for ablation of AVNRT need to be determined in a larger multi-centre trial.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
A. Sandilands, P. Boreham, J. Pitts-Crick, and T. Cripps
Impact of cryoablation catheter size on success rates in the treatment of atrioventricular nodal re-entry tachycardia in 160 patients with long-term follow-up
Europace, June 1, 2008; 10(6): 683 - 686.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. E. Eckart and L. M. Epstein
Interventional Therapy for Atrial and Ventricular Arrhythmias
Card. Surg. Adult, January 1, 2008; 3(2008): 1357 - 1374.
[Full Text]


Home page
EuropaceHome page
P. Khairy, P. G. Novak, P. G. Guerra, I. Greiss, L. Macle, D. Roy, M. Talajic, B. Thibault, and M. Dubuc
Cryothermal slow pathway modification for atrioventricular nodal reentrant tachycardia
Europace, October 1, 2007; 9(10): 909 - 914.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G.P. Kimman, T. Szili-Torok, and L. J. Jordaens
Tachyarrhythmias in Koch's triangle: to be burned out or to be cool?
Europace, October 1, 2007; 9(10): 906 - 908.
[Full Text] [PDF]


Home page
EuropaceHome page
A. De Sisti, J. Tonet, N. Barakett, J. Lacotte, J.F. Leclercq, and R. Frank
Transvenous cryo-ablation of the slow pathway for the treatment of atrioventricular nodal re-entrant tachycardia: a single-centre initial experience study
Europace, June 1, 2007; 9(6): 401 - 406.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
D. Gupta, R. K. Al-Lamee, M. J. Earley, P. Kistler, S. J. Harris, A. W. Nathan, S. C. Sporton, and R. J. Schilling
Cryoablation compared with radiofrequency ablation for atrioventricular nodal re-entrant tachycardia: analysis of factors contributing to acute and follow-up outcome
Europace, December 1, 2006; 8(12): 1022 - 1026.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G.-J. P. Kimman, D. A.M.J. Theuns, P. A. Janse, M. Rivero-Ayerza, M. F. Scholten, T. Szili-Torok, and L. J. Jordaens
One-year follow-up in a prospective, randomized study comparing radiofrequency and cryoablation of arrhythmias in Koch's triangle: clinical symptoms and event recording
Europace, August 1, 2006; 8(8): 592 - 595.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.